相关实验视频

Updated: Jul 16, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

在纳米粒子免疫原体上显示多价抗原会增加B细胞克隆型多样性和对肺炎病毒的中和范围

Sebastian Ols¹, Klara Lenart¹, Rodrigo Arcoverde Cerveira¹

¹Division of Immunology & Allergy, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

|September 9, 2023

概括

多价纳米粒子疫苗通过聚焦抗体特异性来增强B细胞反应,从而导致强大的中和. 这种纳米粒子疫苗设计扩大了免疫反应,以改善疫苗开发.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
纳米技术纳米技术

背景情况:

蛋白子单元疫苗通常会引起低于最佳的B细胞反应.
纳米粒子为多价值抗原显示提供了一个平台,以增强免疫性.
呼吸道同胞性病毒 (RSV) F糖蛋白是亚单元疫苗的关键标.

研究的目的:

为了评估B细胞对RSV F糖蛋白的反应,呈现为trimers与多价值纳米颗粒.
调查多价值显示对抗体特异性和B细胞谱的影响.
确定纳米粒子免疫原体增强B细胞激活和抗体开发的机制.

主要方法:

用RSV F糖蛋白修剪剂或显示10或20个抗原拷贝的纳米颗粒对 rhesus macaques进行免疫接种.
使用抗体克隆和测序分析抗体特异性和B细胞谱.
对RSV和相关肺炎病毒的中和功效和范围的评估.

主要成果:

在纳米颗粒上对RSV F糖蛋白的多价值显示扭曲了抗体特异性并诱导了表位细胞聚焦.
B细胞聚焦是由多样化,克隆上不同的B细胞前体的扩张驱动的.
鉴定出具有增强中和功率或来自低亲和率前体的交叉中和能力的抗体系.
从多价值显示增加的热情促进了这些前体B细胞的激活和招募.

结论:

多价纳米粒子免疫原因通过招募各种前体来使B细胞反应多样化.
通过纳米颗粒介导的增强激情增强了低亲和度B细胞的激活.
这种方法对设计下一代疫苗具有广泛的影响,特别是对于挑战RSV F蛋白等抗原.

关键词:

B 细胞 B 细胞 B 细胞这是一个MPV,MPV.这就是为什么RSV RSV.亲缘关系的值.抗体是一种抗体.这就是贪,贪.克隆性克隆性克隆性免疫原体大小免疫原体大小纳米颗粒疫苗的使用方法价值度价值度价值度价值度

更多相关视频

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

Cross-reactivity

Cross-reactivity

Vaccinations

Vaccinations

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...